Purchase Order 75F40123P00366
Award Date
9/11/23
Potential Completion Date
9/24/24
Potential Value
$208K
Federal Agency
Food and Drug Administration
Awardee
Clarivate Analytics (Us) LLC
Ultimate Awardee
Not listed
NAICS Category
541519 - Other Computer Related Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $227,480 firm fixed price purchase order was awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific research databases and analytics platforms. The contract is for data acquisition services related to active pharmaceutical ingredient (API) manufacturing, with a completion date of September 24, 2023. Clarivate Analytics, a foreign-owned for-profit company, has held multiple indefinite...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to The Pharma Letter LIMITED, a for-profit organization, for a $113,008.00 pharmaceutical subscription for 25 users. The contract has a performance period ending May 20, 2025, with an award date of May 20, 2020. The subscription provides the FDA's Office of Global Policy and Strategy (OGPS) staff with access to global news, expert commentary, and analysis on pharmaceutical, generic,...
This delivery order, awarded by the Department of Health and Human Services' Food and Drug Administration, is for $240,000 worth of pharmaceutical products to support domestic manufacturing and regulatory purposes. We Pharma, Inc. will provide the products in Takoma Park, Maryland by September 30, 2023 under a firm fixed price arrangement. As the FDA works to ensure the safety and effectiveness of drugs and medical devices, this contract will help the agency assess pharmaceutical manufacturing...
The Food and Drug Administration (FDA) awarded a $1,046,568.62 firm-fixed price delivery order to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation, to study the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among individuals being assessed for or entering substance use disorder treatment. This delivery order is part of a larger $10 million indefinite delivery contract the FDA has with Integrated Behavioral Health to...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for a Clarivate Cortellis Pharmaceutical Database subscription. The potential value of this award is $29,806.14 and the performance period runs through September 18, 2023. Clarivate Analytics provides scientific literature database subscriptions and analytics platforms to various federal agencies,...
The Department of Health and Human Services Food and Drug Administration awarded a $1,572,714 firm fixed price delivery order contract to America's Poison Centers. The purpose of this contract is for the prime contractor to acquire access to the National Poison Data System's American Association of Poison Control Centers database to generate frequent surveillance reports and retrospective product analyses. These reports and analyses will provide the FDA specific information on poison exposures...
The Department of Health and Human Services Food and Drug Administration awarded a $169,918.01 firm fixed price delivery order contract to We Pharma, Inc. of Morrisville, North Carolina. The purpose of this requirement is to obtain currently marketed drug products for FDA research studies. We Pharma will provide the requested products to the FDA under this contract, which has a completion date of September 29, 2021. No set-aside designation was used for this award made on September 30, 2020.
Iqvia Government Solutions Inc. was awarded a firm fixed price purchase order contract valued at $2,171,621.71 by the Department of Health and Human Services' Food and Drug Administration to obtain access to data resources enabling global capture of pharmaceutical sales data by country. This contract delivers against the original solicitation requesting pharmaceutical sales information to support the FDA in monitoring drug markets internationally. It was awarded without a set-aside designation...
The U.S. Food and Drug Administration (FDA) awarded a $663,167.34 firm fixed-price purchase order to Clarivate Analytics (Us) LLC for a library subscription to Web of Science, Citation Connection, and InCites. The contract has an ultimate completion date of December 31, 2019 and was awarded on December 30, 2016. Clarivate Analytics (Us) LLC is a global leader in providing scientific, technical, medical, and scholarly research tools and services to federal agencies. This purchase order is not...
The U.S. Food and Drug Administration (FDA), an agency of the Department of Health and Human Services (HHS), has awarded a firm fixed-price purchase order valued at $25,749.97 to Agilent Technologies Inc. for a CFSAN-2023-118815-BNE-GC-MSMS flow modulator. The contract period of performance runs from July 19, 2023 through September 29, 2024. As the prime contractor, Agilent Technologies Inc. will deliver the specified flow modulator to the FDA's Center for Food Safety and Applied Nutrition...